Research programme: T-type calcium channel blockers - DongWoo SyntechAlternative Names: DWKH0090
Latest Information Update: 16 Jul 2016
Price : $50
At a glance
- Originator Dongwoo Syntech Co.
- Class Acetamides; Quinazolines
- Mechanism of Action T type calcium channel antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Cancer in South Korea
- 20 Aug 2009 Preclinical trials in Cancer in South Korea (unspecified route)